No. |
Product Name |
CAS No. |
Spec |
Price |
|
1448628 |
Moxifloxacin Related Compound B (25 mg) (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) |
N/A |
|
|
1448639 |
Moxifloxacin Related Compound C (25 mg) (1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) |
N/A |
|
|
1448655 |
Moxifloxacin Related Compound E (25 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride) |
N/A |
|
|
1448854 |
Low Molecular Weight Heparin Molecular Weight Calibrant (10.6 mg) |
N/A |
|
|
1448901 |
Mupirocin (50 mg) |
12650-69-0 |
|
|
1448912 |
Mupirocin Calcium (200 mg) |
115074-43-6 |
|
|
1448923 |
Mupirocin Lithium (100 mg) |
73346-79-9 |
|
|
1448956 |
Mycophenolate Mofetil (200 mg) |
128794-94-5 |
|
|
1448967 |
Mycophenolate Mofetil Related Compound A (15 mg) (2-morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate) |
N/A |
|
|
1448978 |
Mycophenolate Mofetil Related Compound B (15 mg) [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one] |
79081-87-1 |
|
|
1448990 |
Myristic Acid (200 mg) |
544-63-8 |
|
|
1449008 |
Myristyl Alcohol (1 g) |
112-72-1 |
|
|
1449518 |
Nabumetone (200 mg) |
42924-53-8 |
|
|
1449530 |
Nabumetone Related Compound A (15 mg) (1-(6-methoxy-2-naphthyl)-but-1-en-3-one) |
N/A |
|
|
1449700 |
Nadolol (200 mg) |
42200-33-9 |
|
|
1450007 |
Nafcillin Sodium (200 mg) |
7177-50-6 |
|
|
1450404 |
Naftifine Hydrochloride (200 mg) |
65473-14-5 |
|
|
1451000 |
Nalidixic Acid (200 mg) |
389-08-2 |
|
|
1452002 |
Nalorphine Hydrochloride CIII (250 mg) |
57-29-4 |
|
|
1453005 |
Naloxone (125 mg) |
465-65-6 |
|
|